$Big Tree Cloud (DSY.US)$Arrived 🚀
Translated
1
$Novavax (NVAX.US)$
Furui Group analyst Roger Song maintains novavax (NVAX.US)a buy rating, maintaining a target price of $31.
Furui Group analyst Roger Song maintains novavax (NVAX.US)a buy rating, maintaining a target price of $31.
Translated
$Novavax (NVAX.US)$ said Friday that doses of its updated vaccine to prevent COVID-19 in people at least 12 years old are now available in the US.
The company said its 2024-2025 formula COVID-19 vaccine is in stock at major pharmacy retailers nationwide.
The company said its 2024-2025 formula COVID-19 vaccine is in stock at major pharmacy retailers nationwide.
3
1
$Novavax (NVAX.US)$
The airplane is starting to take off ✈️
The airplane is starting to take off ✈️
Translated
1
1
$Aethlon Medical (AEMD.US)$
Today, close to 100,000 mpox vaccine doses will arrive in the Democratic Republic of Congo (DRC), making these the first delivery of the vaccine to the country. A second delivery amounting to around 100,000 vaccines is expected to arrive in the coming days.
Today, close to 100,000 mpox vaccine doses will arrive in the Democratic Republic of Congo (DRC), making these the first delivery of the vaccine to the country. A second delivery amounting to around 100,000 vaccines is expected to arrive in the coming days.
3
$Novavax (NVAX.US)$
Six American biotechnology analysts have indicated that Novavax is approaching break-even. They forecast that the company will announce its final loss in 2024 and then achieve a profit of $29 million in 2025. Therefore, it is expected that the company will achieve a break-even point in just over a year. In order to reach the break-even point by 2025, the company must grow at what rate per year? According to the analysts' estimates, they expect the company to grow by an average of 76% year-on-year, which suggests that the analysts are confident. If the business growth rate slows down, the time to profitability will be later than expected.
Six American biotechnology analysts have indicated that Novavax is approaching break-even. They forecast that the company will announce its final loss in 2024 and then achieve a profit of $29 million in 2025. Therefore, it is expected that the company will achieve a break-even point in just over a year. In order to reach the break-even point by 2025, the company must grow at what rate per year? According to the analysts' estimates, they expect the company to grow by an average of 76% year-on-year, which suggests that the analysts are confident. If the business growth rate slows down, the time to profitability will be later than expected.
Translated
$WiSA Technologies (WISA.US)$
Ready to take off 🛫
Ready to take off 🛫
Translated
$Big Tree Cloud (DSY.US)$
What's the situation with the continuous rise?
What's the situation with the continuous rise?
Translated
$Candel Therapeutics (CADL.US)$
✈️Here comes.
✈️Here comes.
Translated
$Novavax (NVAX.US)$
The plane has taken off ✈️
The plane has taken off ✈️
Translated
2